Search research articles
Contact Us
Filters
Showing results (101-110 of 106) with videos related to
Page
of 11
Sort By:
You have reached the last page of results.
This site can display upto 106 results.
Neurobiology of Disease
|
January 15, 2026
Association between plasma glucosylsphingosine levels and dyskinesia burden in GBA1-related Parkinson's disease
Massimo Marano, Carmela Zizzo, Francesco Cavallieri, et al.
Neurology
|
October 22, 2025
Long-Term Motor and Cognitive Outcome of Deep Brain Stimulation in Patients With Parkinson Disease With a <i>GBA1</i> Pathogenic Variant
Micol Avenali, Carlo Alberto Artusi, Roberto Cilia, et al.
European Journal of Neurology
|
July 15, 2025
Effects of GBA1 Variants in Patients With Parkinson's Disease and Levodopa-Carbidopa Intestinal Gel: A Nation-Wide, Multicenter, Longitudinal, "Real-World" Study. The EPIC Study
Roberto Cilia, Fabiana Colucci, Emanuele Cereda, et al.
Nature Communications
|
April 15, 2026
Variants in the proteasome regulator PSMF1 cause a phenotypic spectrum from parkinsonism to perinatal lethality
Francesca Magrinelli, Christelle Tesson, Plamena R Angelova, et al.
Plos One
|
June 2, 2022
Prognostic indicators and outcomes of hospitalised COVID-19 patients with neurological disease: An individual patient data meta-analysis
Bhagteshwar Singh, Suzannah Lant, Sofia Cividini, et al.
Brain : a Journal of Neurology
|
August 1, 2024
Relevance of genetic testing in the gene-targeted trial era: the Rostock Parkinson's disease study
Ana Westenberger, Volha Skrahina, Tatiana Usnich, et al.
Page
of 11
Search research articles
Search
Showing results (101-110 of 106) with videos related to
Sort By:
Page
of 11
You have reached the last page of results.
This site can display upto 106 results.
Neurobiology of Disease
|
January 15, 2026
Association between plasma glucosylsphingosine levels and dyskinesia burden in GBA1-related Parkinson's disease
Massimo Marano, Carmela Zizzo, Francesco Cavallieri, et al.
Neurology
|
October 22, 2025
Long-Term Motor and Cognitive Outcome of Deep Brain Stimulation in Patients With Parkinson Disease With a <i>GBA1</i> Pathogenic Variant
Micol Avenali, Carlo Alberto Artusi, Roberto Cilia, et al.
European Journal of Neurology
|
July 15, 2025
Effects of GBA1 Variants in Patients With Parkinson's Disease and Levodopa-Carbidopa Intestinal Gel: A Nation-Wide, Multicenter, Longitudinal, "Real-World" Study. The EPIC Study
Roberto Cilia, Fabiana Colucci, Emanuele Cereda, et al.
Nature Communications
|
April 15, 2026
Variants in the proteasome regulator PSMF1 cause a phenotypic spectrum from parkinsonism to perinatal lethality
Francesca Magrinelli, Christelle Tesson, Plamena R Angelova, et al.
Plos One
|
June 2, 2022
Prognostic indicators and outcomes of hospitalised COVID-19 patients with neurological disease: An individual patient data meta-analysis
Bhagteshwar Singh, Suzannah Lant, Sofia Cividini, et al.
Brain : a Journal of Neurology
|
August 1, 2024
Relevance of genetic testing in the gene-targeted trial era: the Rostock Parkinson's disease study
Ana Westenberger, Volha Skrahina, Tatiana Usnich, et al.
Page
of 11